KRAS Mutant Status, p16 and β-catenin Expression May Predict Local Recurrence in Patients Who Underwent Transanal Endoscopic Microsurgery (TEMS) for Stage I Rectal Cancer.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Anticancer Research

• Publication date

  2016-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.21873/ANTICANRES.11104PMID 27798894
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transanal Endoscopic Microsurgery

  2017cited by this paper
• A structured approach to reporting rectal cancer with magnetic resonance imaging

  2015cited by this paper
• DNA Methylation Combinations in Adjacent Normal Colon Tissue Predict Cancer Recurrence: Evidence from a Clinical Cohort Study

  2015cited by this paper
• Use of Preoperative MRI to Select Candidates for Local Excision of MRI-Staged T1 and T2 Rectal Cancer: Can MRI Select Patients With N0 Tumors?

  2015cited by this paper
• Use of Preoperative MRI to Select Candidates for Local Excision of MRI-Staged T1 and T2 Rectal Cancer: Can MRI Select Patients With N0 Tumors?

  2015cited by this paper
• Role of endoscopic ultrasonography in the loco-regional staging of patients with rectal cancer.

  2015cited by this paper
• A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype

  2014cited by this paper
• Relationships Between p16 Gene Promoter Methylation and Clinicopathologic Features of Colorectal Cancer: A Meta-Analysis of 27 Cohort Studies

  2014cited by this paper
• p16 Methylation is frequently detected in the serum of metastatic colorectal cancer patients.

  2014cited by this paper
• Lack of KRAS, NRAS, BRAF and TP53 mutations improves outcome of elderly metastatic colorectal cancer patients treated with cetuximab, oxaliplatin and UFT

  2014cited by this paper
• Role of MGMT as biomarker in colorectal cancer.

  2014cited by this paper
• Mini‐probe ultrasonography for the staging of colon cancer: a systematic review and meta‐analysis

  2014cited by this paper
• BRAF V600E mutation as a predictive factor of anti-EGFR monoclonal antibodies therapeutic effects in metastatic colorectal cancer: a meta-analysis.

  2014cited by this paper
• BRAFV600E Mutation and Its Association with Clinicopathological Features of Colorectal Cancer: A Systematic Review and Meta-Analysis

  2014cited by this paper
• KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer

  2014cited by this paper
• Transanal Endoscopic Microsurgery for the Resection of Submucosal and Retrorectal Tumors

  2013cited by this paper
• The Prognostic Role of BRAF Mutation in Metastatic Colorectal Cancer Receiving Anti-EGFR Monoclonal Antibodies: A Meta-Analysis

  2013cited by this paper
• Complications of Transanal Endoscopic Microsurgery Are Rare and Minor: A Single Institution’s Analysis and Comparison to Existing Data

  2013cited by this paper
• Oncogenic mutations and microsatellite instability phenotype predict specific anatomical subsite in colorectal cancer patients

  2013cited by this paper
• Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication.

  2013cited by this paper
• Use of multivariate analysis to suggest a new molecular classification of colorectal cancer

  2013cited by this paper
• Transanal Endoscopic Proctectomy: An Innovative Procedure for Difficult Resection of Rectal Tumors in Men With Narrow Pelvis

  2013cited by this paper
• Transanal Minimally Invasive Surgery (TAMIS) for Local Excision of Benign Neoplasms and Early-stage Rectal Cancer: Efficacy and Outcomes in the First 50 Patients

  2013cited by this paper
• Transanal endoscopic microsurgery

  2013cited by this paper
• Transanal endoscopic microsurgery versus laparoscopic lower anterior resection for the treatment of T1-2 rectal cancers.

  2013cited by this paper
• Treatment of rectal cancer by transanal endoscopic microsurgery: review of the literature.

  2013cited by this paper
• Transanal endoscopic microsurgery for rectal tumors: an option to radical surgery?

  2013cited by this paper
• Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features

  2013cited by this paper
• Stage III & IV colon and rectal cancers share a similar genetic profile: a review of the Oregon Colorectal Cancer Registry.

  2013cited by this paper
• [Transanal endoscopic microsurgery--our initial experience].

  2012cited by this paper
• Biomarkers in Early-Stage Colorectal Cancer: Ready for Prime Time?

  2012cited by this paper
• The outcome of rectal cancer after early salvage surgery following transanal endoscopic microsurgery seems promising.

  2012cited by this paper
• Local resection for rectal tumors: comparative study of transanal endoscopic microsurgery vs. conventional transanal excision - the experience in China.

  2012cited by this paper
• BRAF Mutation Status and Survival after Colorectal Cancer Diagnosis According to Patient and Tumor Characteristics

  2012cited by this paper
• The Transanal Endoscopic Microsurgery Procedure: Standards and Extended Indications

  2012cited by this paper
• Transanal endoscopic microsurgery in treatment of rectal adenomas and T1 low-risk carcinomas

  2012cited by this paper
• EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib.

  2012cited by this paper
• BRAF Mutations in Colorectal Cancer Are Associated With Distinct Clinical Characteristics and Worse Prognosis

  2012cited by this paper
• Comparison of endoscopic submucosal dissection and endoscopic mucosal resection for large colorectal tumors

  2011cited by this paper
• Cetuximab and panitumumab in KRAS wild-type colorectal cancer: a meta-analysis

  2011cited by this paper
• BRAF V600E mutation and resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer: a meta-analysis

  2011cited by this paper
• Molecular Prognostic and Predictive Markers in Colorectal Cancer: Current Status

  2011cited by this paper
• Advances in the understanding and treatment of colorectal cancer.

  2011cited by this paper
• Impact of KRAS, BRAF, PIK3CA Mutations, PTEN, AREG, EREG Expression and Skin Rash in ≥2nd Line Cetuximab-Based Therapy of Colorectal Cancer Patients

  2011cited by this paper
• Wnt and Kras signaling-dark siblings in lung cancer

  2011cited by this paper
• Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

  2010cited by this paper
• Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?

  2010cited by this paper
• Transcriptional activation of the β‐catenin gene at the invasion front of colorectal liver metastases

  2009cited by this paper
• CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

  2008cited by this paper
• [Transanal endoscopic microsurgery for rectal intraepithelial neoplasia and early rectal carcinoma].

  2008cited by this paper
• [Treatment of rectal tumors with transanal endoscopic microsurgery].

  2005cited by this paper
• International Seminars in Surgical Oncology Transanal Endoscopic Micro-surgery (tems) for the Management of Large or Sessile Rectal Adenomas: a Review of the Technique and Indications Rectal Adenomas and the Dilemmas of Surgical Treatment

  2005cited by this paper

• The Role of KRAS in Endometrial Cancer: A Mini-Review

  2019cites this paper
• Genetics of rectal cancer and novel therapies: primer for radiologists

  2019cites this paper
• Radiotherapy May Offer a Recurrence and Survival Benefit in Rectal Cancers Treated Surgically with Transanal Endoscopic Microsurgery: A Systematic Review and Meta-analysis.

  2018cites this paper
• Medical Policy Transanal Endoscopic Microsurgery

  2018cites this paper
• KRAS Mutant Status May Be Associated with Distant Recurrence in Early-stage Rectal Cancer.

  2017cites this paper